RNWFX
Price
$79.55
Change
-$1.12 (-1.39%)
Updated
Sep 6 closing price
RSENX
Price
$19.48
Change
-$0.33 (-1.67%)
Updated
Sep 6 closing price
Ad is loading...

RNWFX vs RSENX

Header iconRNWFX vs RSENX Comparison
Open Charts RNWFX vs RSENXBanner chart's image
American Funds New World R5
Price$79.55
Change-$1.12 (-1.39%)
VolumeN/A
CapitalizationN/A
Victory Sophus Emerging Markets Y
Price$19.48
Change-$0.33 (-1.67%)
VolumeN/A
CapitalizationN/A
View a ticker or compare two or three
RNWFX vs RSENX Comparison Chart
Loading...
VS
RNWFX vs. RSENX commentary
Sep 08, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is RNWFX is a Buy and RSENX is a StrongSell.

FUNDAMENTALS
Fundamentals
RNWFX has more cash in the bank: 60.1B vs. RSENX (347M). RSENX pays higher dividends than RNWFX: RSENX (2.50) vs RNWFX (1.51). RNWFX was incepted earlier than RSENX: RNWFX (22 years) vs RSENX (16 years). RSENX is a more actively managed with annual turnover of: 72.00 vs. RNWFX (32.00). RNWFX has a lower initial minimum investment than RSENX: RNWFX (250) vs RSENX (1000000). RNWFX annual gain was more profitable for investors over the last year : 11.53 vs. RSENX (9.37). RNWFX return over 5 years is better than : 22.38 vs. RSENX (12.38).
RNWFXRSENXRNWFX / RSENX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence22 years16 years-
Gain YTD7.2456.270116%
Front LoadN/AN/A-
Min. Initial Investment25010000000%
Min. Initial Investment IRAN/AN/A-
Net Assets60.1B347M17,320%
Annual Yield % from dividends1.512.5060%
Returns for 1 year11.539.37123%
Returns for 3 years-15.44-18.3584%
Returns for 5 years22.3812.38181%
Returns for 10 years35.717.17498%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
EGO16.410.29
+1.80%
Eldorado Gold Corp
BIP31.38-0.08
-0.25%
Brookfield Infrastructure Partners LP
KTRA0.17N/A
-2.51%
Kintara Therapeutics
LCTX0.87-0.03
-3.17%
Lineage Cell Therapeutics
NUVB2.88-0.13
-4.32%
Nuvation Bio